EU reviews reports of rare nerve disorder after AstraZeneca’s Covid-19 shotAstraZeneca, Covid-19 Data, COVID-19 shots, COVID-19 Vaccines, European Medicines Agency, Guillain-Barre, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Nerve SyndromesEurope’s medicines regulator is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca’s Covid-19 shots, raising fresh questions about potential side effects of the vaccine. Read more May 7, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/05/EU-reviews-reports-of-rare-nerve-disorder-after-AstraZenecas-COVID-19-shot-Reuters-5-7-21.jpg 503 960 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-05-07 10:37:102021-05-07 12:47:21EU reviews reports of rare nerve disorder after AstraZeneca’s Covid-19 shot